Len May on EndoDNA, Cannabis Science, and the Endocannabinoid System
Bubba Startz introduces Len May, CEO of Endo DNA, discussing his backstory and transition into the cannabis industry. Len shares personal experiences that led him to focus on the endocannabinoid system, explaining its significance and how it relates to individual health. The conversation highlights the services offered by EndoDNA, which aim to personalize cannabis use based on genetic information. Len also addresses the challenges faced by the company and outlines future plans for growth and innovation. The episode concludes with closing remarks and promotional information, providing listeners with insight into Len's journey and EndoDNA's mission.
Key Points
- Personalized cannabis experiences can be optimized by understanding the interplay between plant genetics and human genetics.
- The endocannabinoid system plays a crucial role in maintaining balance in the body, and deficiencies can be addressed through personalized treatment plans using cannabis.
- EndoDNA aims to revolutionize health care by using AI and genetic testing to create personalized treatment plans that are continually optimized through feedback loops and clinical trials.
Chapters
0:00 | |
1:52 | |
4:18 | |
6:48 | |
11:50 | |
18:44 |
Transcript
Loading transcript...
- / -